Chapter 20. Cyclic Nucleotides as Mediators of Drug Action
- 1 January 1975
- book chapter
- Published by Elsevier
- Vol. 10, 192-201
- https://doi.org/10.1016/s0065-7743(08)61008-8
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- The role of cyclic AMP in neoplastic cell growth and regression II. Growth arrest and glucose-6-phosphate dehydrogenase isozyme shift by dibutyryl cyclic AMPBiochemical and Biophysical Research Communications, 1974
- Decreased basal cyclic adenosine 3′,5′-monophosphate levels in Morris hepatoma 5123 t.c.(h)Biochemical and Biophysical Research Communications, 1974
- Cytidine 3′, 5′-monophosphate (cyclic CMP)Biochemical and Biophysical Research Communications, 1974
- Cartilage cyclic nucleotide phosphodiesterase: Inhibition by anti-inflammatory agentsLife Sciences, 1974
- Role of cyclic AMP in the action of antidiuretic hormone on kidneyLife Sciences, 1973
- Possibilities for drug development based on the cyclic AMP systemLife Sciences, 1973
- Adenosine 3′, 5′-monophosphate-dependent protein kinase in adipose tissue: Inhibition by tolbutamideBiochemical and Biophysical Research Communications, 1973
- Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellumBiochemical and Biophysical Research Communications, 1972
- The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellumBiochemical and Biophysical Research Communications, 1970
- The beta adrenergic theory of the atopic abnormality in bronchial asthmaJournal of Allergy, 1968